NO20052803L - Komplekser av e-2-metoksy-n-(3-{4-(3-metyl-pyridin-3-yloksy)-fenylam ino)-kinazolin-6-yl}-allyl)acetamid, deres fremstillingsmate og bruk - Google Patents

Komplekser av e-2-metoksy-n-(3-{4-(3-metyl-pyridin-3-yloksy)-fenylam ino)-kinazolin-6-yl}-allyl)acetamid, deres fremstillingsmate og bruk

Info

Publication number
NO20052803L
NO20052803L NO20052803A NO20052803A NO20052803L NO 20052803 L NO20052803 L NO 20052803L NO 20052803 A NO20052803 A NO 20052803A NO 20052803 A NO20052803 A NO 20052803A NO 20052803 L NO20052803 L NO 20052803L
Authority
NO
Norway
Prior art keywords
complexes
quinazolin
phenylamino
yloxy
acetamide
Prior art date
Application number
NO20052803A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052803D0 (no
Inventor
Zheng Jane Li
John Charles Kath
Joel Morris
Andrew Vincent Trask
Daniel Tyler Richter
Jason Albert Leonard
Carl Brian Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20052803D0 publication Critical patent/NO20052803D0/no
Publication of NO20052803L publication Critical patent/NO20052803L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20052803A 2002-12-19 2005-06-09 Komplekser av e-2-metoksy-n-(3-{4-(3-metyl-pyridin-3-yloksy)-fenylam ino)-kinazolin-6-yl}-allyl)acetamid, deres fremstillingsmate og bruk NO20052803L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43470002P 2002-12-19 2002-12-19
PCT/IB2003/005783 WO2004056802A1 (en) 2002-12-19 2003-12-08 Complexes of e-2-methoxy-n-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide, their method of production, and use

Publications (2)

Publication Number Publication Date
NO20052803D0 NO20052803D0 (no) 2005-06-09
NO20052803L true NO20052803L (no) 2005-09-16

Family

ID=32682089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052803A NO20052803L (no) 2002-12-19 2005-06-09 Komplekser av e-2-metoksy-n-(3-{4-(3-metyl-pyridin-3-yloksy)-fenylam ino)-kinazolin-6-yl}-allyl)acetamid, deres fremstillingsmate og bruk

Country Status (21)

Country Link
US (1) US20050075354A1 (pl)
EP (1) EP1575936A1 (pl)
JP (1) JP2006512355A (pl)
KR (1) KR20050085835A (pl)
CN (1) CN1726208A (pl)
AR (1) AR042508A1 (pl)
AU (1) AU2003283743A1 (pl)
BR (1) BR0317259A (pl)
CA (1) CA2509140A1 (pl)
GT (1) GT200300287A (pl)
MX (1) MXPA05006582A (pl)
NL (1) NL1025072C2 (pl)
NO (1) NO20052803L (pl)
PA (1) PA8592501A1 (pl)
PE (1) PE20040915A1 (pl)
PL (1) PL377533A1 (pl)
RU (1) RU2005122659A (pl)
TW (1) TW200424191A (pl)
UY (1) UY28129A1 (pl)
WO (1) WO2004056802A1 (pl)
ZA (1) ZA200504621B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
JP2008542356A (ja) * 2005-06-03 2008-11-27 ファイザー・プロダクツ・インク 異常な細胞増殖の治療用の二環式誘導体
ES2607806T5 (es) 2010-02-12 2024-10-07 Pfizer Sales y polimorfos de 8-fluoro-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6H-azepino[5,4,3-cd]indol-6-ona
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884418B1 (en) * 1989-08-04 2005-04-26 Berlex Laboratories, Inc. Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
CN1437594A (zh) * 2000-06-22 2003-08-20 辉瑞产品公司 用于治疗异常细胞生长的取代的双环衍生物
DE60223279T2 (de) * 2001-11-30 2008-05-29 Osi Pharmaceuticals, Inc. Verfahren für die herstellung substituierter bicyclischer derivate zur behandlung von anomalem zellwachstum
CN1608062A (zh) * 2001-12-12 2005-04-20 辉瑞产品公司 E－2－甲氧基－n－(3－{4－[3－甲基－4－(6－甲基－吡啶－3－基氧基) －苯氨基]－喹唑啉－6基}－烯丙基)－乙酰胺的盐，其制备和抗癌用途
IL161908A0 (en) * 2001-12-12 2005-11-20 Pfizer Prod Inc Quinazoline derivatives for the treatment of abnormal cell growth

Also Published As

Publication number Publication date
CN1726208A (zh) 2006-01-25
US20050075354A1 (en) 2005-04-07
MXPA05006582A (es) 2005-08-16
RU2005122659A (ru) 2006-01-20
NL1025072C2 (nl) 2007-07-24
PL377533A1 (pl) 2006-02-06
WO2004056802A1 (en) 2004-07-08
NO20052803D0 (no) 2005-06-09
BR0317259A (pt) 2005-11-08
JP2006512355A (ja) 2006-04-13
NL1025072A1 (nl) 2004-06-22
ZA200504621B (en) 2006-03-29
KR20050085835A (ko) 2005-08-29
PA8592501A1 (es) 2004-09-16
UY28129A1 (es) 2004-07-30
AU2003283743A1 (en) 2004-07-14
GT200300287A (es) 2004-11-30
PE20040915A1 (es) 2005-01-18
EP1575936A1 (en) 2005-09-21
CA2509140A1 (en) 2004-07-08
AR042508A1 (es) 2005-06-22
TW200424191A (en) 2004-11-16

Similar Documents

Publication Publication Date Title
MXPA04004301A (es) Bencimidazoles sustituidos utiles como inhibidores de la proteina cinasa.
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
NO20074634L (no) Substituerte heterocykler og deres anvendelse som CHK1-, PDK1- og PAK-inhibitorer
NO20063449L (no) Substituerte heterocykler og deres anvendelse
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
ATE532781T1 (de) 5-(acylamino)indazol-derivate als kinase- inhibitoren
AP2004003059A0 (en) Salt forms of E-2-methoxy-N-(3-(4-(3-methyl-pyridin-3-yloxyl)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
NO20070681L (no) 2, 4, 6-Trisubstituterte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse i behandling av kreft
DE60110749D1 (de) Pyridinderivative als angiogenese- und/oder vegf-rezeptor-tyrosinkinase-inhibitoren
NO20061743L (no) Kinazolinderivater
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
NO20081893L (no) 4-(3-aminopyrazol)pyrimidinderivater til anvendelse som tyrosin-kinaseinhibitorer i behandling av kreft
NO20085217L (no) Effektive pyrimidinderivater i behandlingen av kreft
NO20055496L (no) Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer
EA200802050A1 (ru) Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов
NO20081434L (no) 5-(fenylisoksazolyletoksy)-triazol-3-yl substituert pyridinsammensetninger for behandling av neurologisk, psykiatrisk eller smerteforstyrrelser
NO20070655L (no) 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
NO20070453L (no) Kondenserte heterocykliske kinase inhibitorer
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
DE60215178D1 (de) Quinolin-derivate und ihre verwendung als inhibitoren der tyrosine kinase
NO20071005L (no) Enantiomerer av selekterte kondenserte pyrimidoner og anvendelser for behandling og forebygging av cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application